Left arrow Mur Lura

SPEECH BY THE HON. TONIO FENECH, MINISTER OF FINANCE, THE ECONOMY AND INVESTMENT, AT THE 7TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY IN MALTA - VALLETTA – 8TH MARCH 2010

PR0409
Date Icon 08/03/2010

Ladies and Gentlemen,

It’s a pleasure for me to be present during this World Meeting and to share with you my government’s thoughts on the role of the pharmaceutical industry in Malta and look at some of the important developments taking place in this sector. The pharmaceutical sector is experiencing major changes on a worldwide level. World demand for pharmaceuticals is expected to continue to grow substantially. According to the United States Census Bureau's Global Population Profile, the percentage of people aged 65 and older will grow almost 90% during until 2025 – that’s about 400 million people in real terms. Countries like Brazil, Russia, India and China are becoming more industrialised and as a larger middle class grows, so does demand for quality healthcare. That presents new opportunities for smart companies with the necessary resources and infrastructure. This is resulting in major shifts in company infrastructure. We are seeing increased mergers and acquisitions and like all other industries there is an increased focus on cost containment. All of these factors are forcing pharmaceutical companies to regroup and either reposition themselves as a specialty player in niche markets or expand more aggressively in emerging markets. These trends are seen across the board, not just in sales and marketing, but also in R&D as companies seek to reduce development costs and speed time to market by going to emerging markets. An increased focus on partnerships and open science is also beginning to emerge. All in all, what we are seeing here is slow adaptive change to the external environment, but the trends are already showing clear signs of these shifts, which also mirror the economic change in direction in general. We are all aware that the international economic and financial crisis has had significant repercussions on economies worldwide. It also resulted in a drop in global trade and Malta’s main trading partners also suffered from a reduction in economic activity. Given its high degree of openness, it was inevitable that the international economic environment would affect Malta’s economic performance. The manufacturing sector and the tourism industry, in particular, suffered significant downturns. These developments left their mark on the labour market. On the other hand, certain other activities proved to be relatively more resilient to the negative international economic scenario.

The pharmaceutical and bio-technology sector is one of those sectors that maintained its economic momentum in Malta. We can safely say that it has first survived the economic shocks and now is in a position to consolidate and expand. In fact we are presently holding discussions with a leading foreign owned pharmaceutical company to expand its operations in Malta.

This is not a coincidence. When Malta embarked on its strategy to attract pharmaceutical companies it did so because it was conscious of the high value added of this sector. We have often stated that Malta cannot be competitive in everything, and in fact we are successful only to the extent that we focus in target niches within specific operations – indeed in some cases specific value chains: The generics sub-sector being one of them. The global generic drug industry has witnessed an almost decade-long sales euphoria and volumes and sales growth of prescription generic drugs continued to increase in 2009. In the 12 months ended September 2009, global prescription sales growth of generic drugs climbed by 7.7%, up from 3.6% in 2008. In Malta, the value added of this sector reaches 300% of the average value added of all the direct productive activities. It is by far the sector that contributes mostly to our local added value. Annually each person employed in this sector adds value to around €110,000, whereas the average of the whole manufacturing sector is of €32,000. Employment in this sector has increased by 50% in the last 3 years.

These companies actually employ between them around 1200 persons, that is, 6% of the total population engaged in direct productive activities.

We are happy to host worldwide leaders such as Actavis, Aurobindo, Amino Chemicals, Medichem, Soleapharma, Sterling, Starpharma and Watson Pharmaceuticals among others. These companies originate from Iceland, Ireland, USA, Switzerland, Spain, India and Italy.

This is another proof of the openness of our economy and of the fact that Malta is open to business from all around the globe. It was definitely not easy to attract these companies to Malta. It was not merely a question of promoting our country; we worked hard to build a robust regulatory regime, enhance local skills, upgrade institutions and ensure that these renowned names found all the necessary support in Malta.

We are proud to say that we did not only attract them here, but many of them have also been expanding their operations in the recent years – a further proof that they have found our country an ideal location to operate from.

To support this growth, government invested significantly in the upgrading of human resources through courses at the University of Malta, the Malta College for Arts, Science and Technology and the Employment and Training Corporation. I also have to mention that the industry itself gave substantial contribution in terms of knowledge and lecturing staff to ensure that the academic and vocational training are in line with what the industry itself requires. The contribution of the Malta Chamber of Commerce, Enterprise and Industry, in this regard, has been essential.

We have invested money to train our people. It was a new sector and it was indeed a challenge. We are proud today that we have achieved good results, and we fervently believe that there is room for more international companies to explore the benefit of Malta’s potential. We offer a strong value proposition made up of different components, most importantly:

a. A robust intellectual property legislation; b. An environment where very few patents have been registered thus facilitating generic manufacturing; c. A healthy stable economic environment; d. A competitive production cost structure; e. Medicine registration facilities include the possibility of utilising Malta as a reference member state and thus as a spring board within the EU market; f. Efficient and professional production and marketing certifications by the health authorities; g. Over all support throughout the life time of business.

We are committed to continue providing this support.

Despite the international crisis and the recession we have continued to attract foreign business in a number of sectors and we are confident that our country offers a number of opportunities to those willing to invest not just in pharmaceutical manufacturing but also in the supporting clusters. This is part and parcel of Government’s Vision to become a centre of excellence in manufacturing by 2015. We welcome and support small and big businesses alike and we give them both the same and utmost importance.

From our end, we facilitate the way of doing business but the final word rests with you. We are always open to discuss and support business in the best way possible through good times and bad times. We are ready and committed to meet the challenges and enhance our economic growth through business opportunities that offer a win-win solution to investors and the local community alike.

Thank you for your attention.

Ixxerja din l-istqarrija Icon socials Icon socials Icon socials Icon socials

Stqarrijiet Oħra:

STQARRIJA MILL-MINISTERU GĦALL-AGRIKOLTURA, IS-SAJD U L-PROVVISTA TAL-IKEL  Tittella’ r-raba’ edizzjoni ta’ Porkilicious: inizjattiva li tgħaqqad il-gastronomija u s-sostenibbiltà tal-ikel mal-appoġġ għall-Malta Community Chest Fund

PR261991

STQARRIJA MILL-MINISTERU GĦALL-AGRIKOLTURA, IS-SAJD U L-PROVVISTA TAL-IKEL ...

STQARRIJA MILL-MINISTERU GĦALL-EDUKAZZJONI U L-ISPORT  “L-intelliġenza artifiċjali għandha tkun għodda mħaddma tajjeb, filwaqt li qatt ma tista’ tieħu r-rwol fundamentali tal-edukaturi” – Il-Ministru Byron Camilleri fi Brussell

PR261990

STQARRIJA MILL-MINISTERU GĦALL-EDUKAZZJONI U L-ISPORT “L-intelliġenza arti...

Aktar Stqarrijiet Right arrow